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o analyze the implication of PTEN in the control of
tumor cell invasiveness, the canine kidney epithelial
cell lines MDCK
 
ras
 
-f and MDCKts-
 
src
 
, expressing
activated Ras and a temperature-sensitive v-Src tyrosine
kinase, respectively, were transfected with PTEN expression
vectors. Likewise, the human PTEN-defective glioblastoma
cell lines U87MG and U373MG, the melanoma cell line
FM-45, and the prostate carcinoma cell line PC-3 were
transfected. We demonstrate that ectopic expression of
wild-type PTEN in MDCKts-
 
src
 
 cells, but not expression of
PTEN mutants deficient in either the lipid or both the
lipid and protein phosphatase activities, reverted the
morphological transformation, induced cell–cell aggregation,
and suppressed the invasive phenotype in an E-cadherin–
T
 
dependent manner. In contrast, overexpression of wild-type
PTEN did not counteract Ras-induced invasiveness of
 
MDCK
 
ras
 
-f cells expressing low levels of E-cadherin.
PTEN effects were not associated with marked changes in
accumulation or phosphorylation levels of E-cadherin and
associated catenins. Wild-type, but not mutant, PTEN also
reverted the invasive phenotype of U87MG, U373MG, PC-3,
and FM-45 cells. Interestingly, PTEN effects were mimicked
by N-cadherin–neutralizing antibody in the glioblastoma
 
cell lines. Our data confirm the differential activities of
E- and N-cadherin on invasiveness and suggest that the
lipid phosphatase activity of PTEN exerts a critical role in
stabilizing junctional complexes and restraining invasiveness.
 
Introduction
 
Neoplastic progression results from the dysregulation of a
series of proto-oncogenes and tumor suppressor genes. In
this context, the recently discovered PTEN (phosphatase
and tensin homologue deleted from chromosome 10) tumor
suppressor gene has been found to be defective in a large num-
ber of human cancers, including glioblastomas, endometrial,
prostate, and renal cancers, as well as melanomas (Cantley
and Neel, 1999). The hallmark of malignancy is the acquisi-
tion of the invasive phenotype. This process involves break-
down of cell–cell junctions, increased motility of tumor
cells, and focal proteolysis of the extracellular matrix.
 
Among junctional complexes, the E-cadherin–catenin system
 
exerts a critical role in the control of carcinogenesis. These com-
plexes are subjected to inactivation by multiple mechanisms,
including both genetic and epigenetic events. Accordingly,
activation of the Src tyrosine kinase switches E-cadherin
junctions from a strong to a weak state and induces the invasive
phenotype in epithelial canine kidney MDCKts-
 
src
 
 cells,
transformed by a temperature-sensitive v-Src tyrosine kinase
(pp60
 
v-src
 
) (Behrens et al., 1989, 1993; Takeda et al., 1995).
Several lines of evidence suggest that PTEN might partici-
pate in regulating cell–cell junctions and tumor cell invasion.
The amino terminus of PTEN shows homology with tensin,
a protein interacting with actin at focal adhesions, and its
carboxy terminus encodes a potential PDZ binding motif.
Proteins with PDZ domains, such as ZO-1, direct the as-
sembly of multiprotein complexes, often at membrane–
cytoskeletal interfaces. Furthermore, characterization of
PTEN activity revealed that it is a phosphatase that acts on
both phosphotyrosine residues and the D3 position of
phosphatidylinositol-3,4,5-trisphosphate, the product of
phosphatidylinositol 3-OH kinase (PI3-kinase)* (Furnari et
al., 1998; Myers et al., 1998). The PTEN mutations so far
identified affect either the phosphatidylinositol phosphatase,
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or both phosphatidylinositol and protein phosphatase activi-
ties. We have previously demonstrated an involvement of
the PI3-kinase signaling pathway in inducing the invasive
phenotype of MDCKts-
 
src
 
 cells (Kotelevets et al., 1998). It
has also been reported that PTEN selectively dephosphory-
lates focal adhesion kinase, and it inhibits the motility of fi-
broblasts and the invasiveness of U87MG glioma cells
(Tamura et al., 1998, 1999).
To delineate the involvement of PTEN in the control of tu-
mor cell scattering and invasiveness, and to investigate the
cross-talk between PTEN and the Ras and Src oncogenic
pathways on the one hand, and cadherin junctional com-
plexes on the other, we transfected MDCK
 
ras
 
-f and
MDCKts-
 
src
 
 cells and several human, PTEN-defective tumor
cell lines with vectors expressing either wild-type PTEN or
PTEN mutants deficient in either the phosphoinositide phos-
phatase or both the protein and phosphoinositide phosphatase
activities. We evaluated morphological conversion, invasion
into type I collagen, cell aggregation, and the expression, com-
position, phosphorylation level, and subcellular localization of
cadherin-containing junctional complexes.
 
Results and discussion
 
PTEN reverses the morphological conversion induced 
by pp60
 
v-src
 
 
 
To investigate the cross-talk between the PTEN and the Src
and Ras oncogenic pathways, we expressed wild-type PTEN
and lipid phosphatase– or phosphatase-deficient PTEN mu-
tants in MDCK cells, transformed by either a temperature-
sensitive mutant of v-Src (MDCKts-
 
src
 
 cells) (Behrens et al.,
1989, 1993; Takeda et al., 1995) or v-Ras (MDCK
 
ras
 
-f)
(Vleminckx et al., 1991). It was previously demonstrated
that PTEN mutation 
 

 
237–239 results in a 10-fold de-
crease in phosphatase activity toward phosphatidylinositol
(1,3,4,5)P
 
4
 
 without affecting protein phosphatase activity,
whereas PTEN mutations 
 

 
55–70 and C124A affect both
the lipid and protein phosphatase activities of PTEN (Fur-
nari et al., 1998; Tamura et al., 1998). PTEN expression in
transformants was assessed by immunoblotting using anti-
tag antibodies (anti-Xpress or anti-HA) as well as anti-
PTEN antibody (Fig. 1 A). In MDCKts-
 
src
 
 cells, PTEN
overexpression affected neither the phosphorylation of focal
Figure 1. Effect of functional transfer of wild-type or mutant PTEN expression vectors on the morphology of MDCKts-src. (A) Analysis of 
PTEN expression. The ectopic expression of wild-type and PTEN mutants deficient in either the lipid phosphatase activity (PTEN237–239) or 
both the protein and lipid phosphatase activities (PTEN 55–70) was assessed by Western blot using antibodies directed against PTEN, or 
against the Xpress or HA epitopes. Cell lines are indicated as parental (p) or as transfected clone numbers. (B) Analysis of Akt activity. Akt 
phosphorylation, which is a measurement of Akt activity, was analyzed with anti–phospho-Akt(Ser 473) antibody in cell lysates from parental 
MDCKts-src cells (p) and their derivatives transfected with either wild-type (clone 18) or mutant PTEN. Growth was either at the nonpermissive 
temperature for Src activity (40C) or after transfer to 35C for 1 or 18 h as indicated. The total amount of Akt was assessed using anti-Akt 
antibody. (C) Morphology of parental MDCKts-src cells and their derivatives transfected with either wild-type or mutant PTEN. MDCKts-src 
cells exhibited an epithelial morphology at 40C and a fibroblast-like morphology when grown for 14 h at the permissive temperature for Src 
activity (35C). Neither lipid phosphatase–deficient (PTEN237–239) nor the phosphatase-inactive (PTEN 55–70) PTEN mutants preserved 
the epithelial morphology at the permissive temperature as the wild-type PTEN did. Bar, 20 m.
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adhesion kinase nor the MAPK and PI3-kinase activities
(unpublished data). In contrast, the ectopic expression of
wild-type PTEN, but not PTEN mutants, reduced the
phosphorylation of Akt, a downstream target of PI3-kinase,
as shown in Fig. 1 B and in line with previous reports for
other cell lines (Myers et al., 1998).
The possible cross-talk between PTEN and Src signaling
pathways was first assessed at the morphological level. At
the nonpermissive temperature for Src activity (40
 

 
C),
both parental MDCKts-
 
src
 
 and MDCKts-
 
src
 
PTENwt cells
grew as small clusters of adherent cells with few membrane
ruffles or lamellipodia. Switching the MDCKts-
 
src
 
 cells to
the permissive temperature induced a fibroblast-like mor-
photype. The first effects were apparent 4 to 6 h after the
temperature shift, as cells formed prominent lamellipodia
and began to acquire the fibroblastic morphotype. 14 h af-
ter the shift, colonies of cells were almost completely dis-
sociated (Fig. 1 C). Similar results were obtained in
MDCKts-
 
src
 
PTEN
 

 
237–239 expressing the lipid phos-
phatase–deficient PTEN mutant, as well as the MDCKts-
 
src
 
PTEN
 

 
55–70 expressing inactive PTEN (Fig. 1 C). In
contrast, after a 14-h incubation at 35
 

 
C, MDCKts-
 
src
 
PTENwt retained a polygonal epithelioid morphotype,
and cell clusters remained largely intact. In addition, wild-
type PTEN delayed the scattering of MDCKts-
 
src
 
PTENwt
cells as compared with the parental cell line in wound heal-
ing assays (unpublished data).
 
Inhibition of pp60
 
v-src
 
-induced invasiveness by
wild-type PTEN
 
Because PTEN interfered with Src-induced cell scattering,
we further investigated the invasive properties of parental
and PTEN-transfected MDCKts-
 
src
 
 cells in type I collagen
gels. As shown in Fig. 2 A, the parental MDCKts-
 
src
 
 cells
and those derivatives that did not express exogenous PTEN,
MDCKts-
 
src
 
11 and MDCKts-
 
src
 
31, became invasive after a
temperature shift to 35
 

 
C. In contrast, the six MDCKts-
 
src
 
PTENwt clones that overexpressed wild-type PTEN re-
mained noninvasive at the permissive temperature (Fig. 2
A). Overexpression of PTEN mutants in MDCKts-
 
src
 
 cells
did not revert the invasive phenotype induced by Src at
35
 

 
C, demonstrating the critical role of the PTEN lipid
phosphatase activity in the control of the invasive pheno-
type. Besides the lipid phosphatase activity of PTEN, inva-
sion suppression clearly involved the E-cadherin system, as
inactivation of E-cadherin by DECMA-1 mAb induced the
invasive phenotype in MDCKts-
 
src
 
PTENwt, both at the re-
strictive and the permissive temperature for Src activity (Fig.
2 A). Likewise, PTEN could not counteract the invasive
phenotype of MDCK
 
ras
 
-f cells that poorly expressed E-cad-
herins (Vleminckx et al., 1991).
 
Stabilization of E-cadherin junctional complexes by PTEN
 
To gain further insight into the mechanisms involved in
the PTEN-mediated reversion of Src-induced cell scatter-
Figure 2. Effects of PTEN expression on the invasive 
phenotype and cell aggregation of the MDCKts-src 
and MDCKras-f cell lines. (A) Invasion of type I collagen. 
MDCKts-src, MDCKras-f cells, and their derivatives 
transfected by wild-type or mutant PTEN were seeded 
on type I collagen gel at the restrictive or permissive 
temperature for Src activity (MDCKts-src) or at 37C 
(MDCKras-f cells), and the number and depth of cells 
inside the gel were measured after 24 h. The depen-
dence of this process on E-cadherin function was 
assessed by the inactivation of E-cadherin with 
DECMA-1 mAb. (B) Fast aggregation assay. The 
activity of junctional complexes in MDCKts-src cells 
and their derivatives was assessed by the distribution 
of the size of cell aggregates evaluated at t0 () or after 
a 30-min incubation (t30). Aggregation of parental cells 
for 30 min at 40C yielded curves corresponding to 
particles with large size (left panel, ). The same was 
observed for PTEN (wild-type or mutant) transfectants 
at 40C (unpublished data). Src activation at 35C 
impaired aggregation of the parental MDCKts-src cells 
and derivatives expressing mutant PTEN (PTEN 237–
239/71, PTEN 55–70/3, and unpublished data) yield-
ing curves coinciding with the t0 curves (similar results 
were obtained with the MDCKts-src55–70 /9 and 
MDCKts-srcC124A/11 cells; unpublished data). In 
contrast, aggregation of MDCKts-srcPTENwt3 cells 
for 30 min at 35C yielded a curve corresponding 
to large cell aggregates, which can be superimposed 
on the one measured at 40C (unpublished data). 
Treatment with mAb DECMA-1 against E-cadherin at 
the restrictive () or the permissive () temperature 
for Src activity abolished aggregation in all cell types.
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ing and invasiveness, we used the fast aggregation assay to
test whether PTEN activity affects the E-cadherin–depen-
dent adhesion system. A prominent feature of suspended
parental MDCKts-
 
src
 
 cells is the inability to aggregate at
the permissive temperature, whereas cell aggregates form
readily in an E-cadherin–dependent manner at the restric-
tive temperature (Fig. 2 B, left). In contrast, wild-type
PTEN but not mutant PTEN transfectants (
 

 
237–239/
71, 
 

 
55–70/3, and C124A/11) formed aggregates at the
permissive temperature for Src activity (35
 

 
C). All aggrega-
tions observed here were impaired by the E-cadherin neu-
tralizing antibody DECMA-1 (Fig. 2 B). These results
confirmed the critical role of the lipid phosphatase activity
of PTEN in stabilizing E-cadherin junctions and reverting
cell scattering and invasiveness.
 
Effect of PTEN on E-cadherin–catenin complexes
 
We next compared the expression, phosphorylation level,
and cellular localization of E-cadherin and associated pro-
teins in MDCKts-
 
src
 
 and MDCKts-
 
src
 
PTENwt cells before
and after a shift to the permissive temperature for Src activ-
ity. At the restrictive temperature, the E-cadherin signal was
 
concentrated at cell–cell contacts (Fig. 3 A). Time-course
studies showed that Src activation in MDCKts-
 
src
 
 cells re-
sulted in progressive reduction of junctional complexes, de-
localization of E-cadherin from the cell surface, and loss of
epithelioid morphotype (Fig. 3, B and C). In contrast,
MDCKts-
 
src
 
PTENwt cells preserved cell–cell junctions and
E-cadherin localization for longer times (Fig. 3, D–F). The
same was observed for 
 

 
-catenin, 
 

 
-catenin, and p120
 
ctn
 
(unpublished data).
Because E-cadherin activity crucially depends on its asso-
ciation with several cytoplasmic proteins, we analyzed the
total amount of E-cadherin, and associated 
 

 
-catenin, 
 

 
-cat-
enin, and p120
 
ctn
 
. We found that any of these expression
levels were similar at both nonpermissive and permissive
temperatures and also not significantly altered by PTEN
expression (Fig. 4 A). In addition, Src-induced tyrosine
phosphorylation of E-cadherin and associated catenins was
comparable in MDCKts-
 
src
 
 cells and their PTEN deriva-
tives (Fig. 4 B). Thus, in the presence of wild-type PTEN,
Src-induced tyrosine phosphorylation of E-cadherin junc-
tional complexes is not sufficient to promote the disruption
of adherens junctions.
Figure 3. Immunofluorescent staining of 
E-cadherin in parental MDCKts-src cells 
and their wild-type PTEN transfectants 
grown at 40C or after switch to 35C. 
E-cadherin is concentrated at cell–cell 
contacts at the nonpermissive tempera-
ture for Src activity. Note that it is more 
diffusely distributed over the surface of 
dissociated MDCKts-src cells at the 
permissive temperature but largely 
concentrated at sites of cell–cell contacts 
in MDCKts-srcPTENwt18 cells. 
Bar, 10 m.
Figure 4. Effects of wild-type or mutant PTEN expression on the accumulation and phosphorylation levels of E-cadherin and associated 
proteins in MDCKts-src cells and derivatives. (A) Western blotting of E-cadherin, -catenin, -catenin, and p120ctn in total cell lysates at 
permissive and nonpermissive temperature for Src activity. (B) Cell lysates from MDCK, MDCKts-src, and their derivatives grown at 37C, 
40C, or 35C were immunoprecipitated with the E-cadherin–specific mAb DECMA-1. The tyrosine phosphorylated components of cadherin–
catenin complexes were revealed using the PY20 mAb and the ECL system.
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Reversion of invasiveness of PTEN-defective human 
cell lines after restoration of PTEN expression 
To further extend the effects of PTEN on the stabilization of
junctional complexes and the reversion of the invasive
phenotype, we restored PTEN expression in human cell
lines known to be PTEN defective: glioblastoma cell lines
U87MG and U373MG, melanoma cell line FM-45, and
prostate carcinoma cell line PC-3 (Guldberg et al., 1997;
Tamura et al., 1998; Whang et al., 1998). We first analyzed
the expression patterns of epithelial E-cadherin, mesenchy-
mal N-cadherin, and cadherin-11 (Fig. 5 A). All three cad-
herins were found to be expressed in PC-3 cells, which are
known to be defective in Ca2-dependent cell aggregation
due to E-catenin defects (Morton et al., 1993). In contrast,
the U87MG and U373MG glioblastoma cells expressed
mainly N-cadherin, and FM-45 melanoma cells were fea-
tured by weak expression of N-cadherin and major expres-
sion of cadherin-11. A small amount of the latter cadherin
was also identified in U373MG cells. In agreement with the
results obtained from MDCKts-src cells, wild-type PTEN
reverted the invasive phenotype of U87MG and U373MG
glioblastoma cells stably transfected by wild-type PTEN,
and of FM-45 melanoma and PC-3 prostate carcinoma cells
transiently transfected using vaccinia virus–mediated PTEN
expression (Fig. 5, B and C). In the latter two cell lines,
overexpression of mutant PTEN molecules did not revert
the invasive phenotype (Fig. 5 C). These results confirm the
critical role of the lipid phosphatase activity of PTEN in reg-
ulating invasiveness. Moreover, the invasive phenotype of
the U87MG and U373MG glioblastoma cell lines was
clearly dependent on N-cadherin activity, because it was in-
hibited after application of the N-cadherin blocking anti-
body GC-4 (Fig. 5 C), whereas it was noneffective on FM-
45 cells that express mainly cadherin-11 (Fig. 5 A, and un-
published data). Nonetheless, PTEN-mediated invasion
suppression was not associated with any significant change
in the expression pattern of cadherins (Fig. 5 A, and unpub-
lished data).
Several studies have demonstrated that the switch in ex-
pression from E-cadherin to either N-cadherin or cadherin-
11, as observed regularly in melanoma and prostate cancer
cells, might promote cell motility (Tomita et al., 2000; Li et
al., 2001). Whereas E-cadherin mediates tight cell–cell ad-
hesion, the mesenchymal N-cadherin and cadherin-11 exert
a dual activity on both cell–cell interactions and cell motility
and invasiveness. N-cadherin and cadherin-11 might also
exert a dominant effect over E-cadherin, as demonstrated in
breast cancer cells after ectopic expression of N-cadherin
(Nieman et al., 1999; Hazan et al., 2000). Because the
N-cadherin–mediated survival and cell motility of mela-
noma cell lines seem to involve the PI3 kinase pathway (Li et
al., 2001), PTEN might function as a potent gate keeper to
counteract invasiveness mediated by mesenchymal cad-
herins. In consequence, PTEN inactivation during tumor
progression might favor tumor cell dissemination.
Altogether, our data demonstrate that PTEN constitutes a
critical effector in controlling the invasive phenotype. Be-
cause PTEN inactivation occurs in a wide range of tumors,
we propose that PTEN can regulate the noninvasive pheno-
type via both E-cadherin–dependent and –independent
pathways, according to the cellular context: (a) stabilization
of E-cadherin complexes; (b) reversion of the activity and ef-
fector systems of mesenchymal cadherins; and (c) modula-
tion of cell–matrix adhesion complexes through integrin and
cytoskeleton reorganization. Development of therapeutic
strategies targeting the many effector systems controlled by
Figure 5. Effect of restoration of PTEN 
expression on the invasive phenotype of 
the PTEN-defective human melanoma 
cell line FM-45, the prostate carci-
noma cell line PC-3, and the glioblas-
toma cell lines U87MG and U373MG. 
(A) Immunoblot analysis of E-cadherin, 
N-cadherin, and cadherin-11. Cell 
lysates (50 g protein for all cell
lines except for U87MGwt14 and 
U373MGwt16 lysates for which 30 
g was used) were immunoblotted 
with mAbs directed against E-cadherin 
(MB-2 and HECD-1), N-cadherin 
(Zymed), or cadherin-11 (113H), and 
probed using the ECL system. (B) Analysis 
of PTEN expression in U87MG and 
U373MG cells and their derivatives 
stably transfected by wild-type PTEN, 
and in FM-45 and PC-3 cell lines 
transiently expressing wild-type or 
mutant GFP–PTEN upon vaccinia 
infection. Cell lysates (100 g protein) 
from parental and PTEN-transfected 
cells were immunoblotted with mAbs 
directed against PTEN. (C) Invasion of 
type I collagen by U87, U373, FM-45, 
and PC-3 cells and their derivatives transfected by wild-type or mutant PTEN. Cells were seeded on type I collagen gels at 37C and the 
number and depth of cells inside the gel were measured after 24 h. The dependence of cell migration and invasion on N-cadherin was 
assessed by the blocking of N-cadherin using GC-4 antibodies (dilution 1:50).
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PTEN may not only suppress tumor growth and induce
apoptosis, but holds also the promise to restrain tumor cell
dissemination and metastasis.
Materials and methods
Plasmid construction and cell transfection
Full-length wild-type PTEN cDNA and phosphatase inactive PTEN mutant
55–70 were generated by RT-PCR of RNA extracted from human colonic
crypts and the invasive glioblastoma cell line 149, respectively. The result-
ing PCR products were subcloned into pcDNA-His (Invitrogen), in frame
with the NH2-terminal Xpress epitope. Expression vectors encoding wild-
type PTEN or the phosphophatidylinositol phosphatase inactive PTEN mu-
tant 237–239 fused with the HA epitope (Furnari et al., 1998) were
provided by Dr. F.B. Furnari (University of California, San Diego, CA). Ex-
pression vectors encoding green fluorescent protein (GFP)–tagged wild-
type PTEN or phosphatase inactive PTEN mutant C124A (Tamura et al.,
1998) were provided by Dr. K.M. Yamada (National Institutes of Health,
Bethesda, MD).
The MDCKts-src clone 2 and MDCKras-f cell lines expressing, respec-
tively, thermosensitive v-Src and activated Ras, have been previously es-
tablished by infection of MDCK cells with either a murine leukemia retro-
viral construct recombined with a thermosensitive v-src gene or the
Harvey murine sarcoma virus (Behrens et al., 1989, 1993; Vleminckx et
al., 1991; Takeda et al., 1995). MDCKts-src clone 2 and MDCKras-f cells,
and the U87 and U373 glioblastoma cell lines were transfected with PTEN
expression vectors, using lipofectamine (GIBCO BRL) as previously de-
scribed (Kotelevets et al., 1998). The PTEN C124A construct that lacks a
selection marker was cotransfected with pcDNA3.1 plasmid (Invitrogen),
conferring G418 resistance. After selection for 2 wk with 500 g/ml G418
(Xpress-tagged constructs, PTENC124A) or 4 g/ml puromycin (HA-tagged
constructs), colonies of growing, surviving cells were randomly picked up,
amplified, and evaluated for expression of the transgene by Western blot-
ting.
For vaccinia virus–mediated transient overexpression, wild-type and
mutant (237–239 and 55–70) PTEN cDNAs were subcloned in the pE/L-
GFP vector, in frame with the GFP tag (Frischknecht et al., 1999). FM-45
and PC-3 cells were transfected with Lipofectin (Life Technologies) and si-
multaneously coinfected with vaccinia virus strain A36R, which does not
make actin tails. 10 h after transfection, PTEN cDNAs, under the control of
the vaccinia virus early/late promoter, were expressed at high levels. The
pE/L-GFP vector and vaccinia virus strain A36R were provided by Dr. F.
Frischknecht (European Molecular Biology Laboratory, Heidelberg, Ger-
many) and B. Janssens (VIB-Ghent University, Ghent, Belgium).
Collagen type I invasion and fast aggregation assays
Single-cell suspensions were seeded on top of the type I collagen gel (Up-
state Biotechnology), and cultures were incubated for 24 h at 35C, 37C, or
40C. Using an inverted microscope controlled by a computer program (Va-
kaet et al., 1991), we counted the invasive and superficial cells in 12 fields
of 0.157 mm2. The invasion index was expressed as the percentage of cells
invading the gel over the total number of cells (Vleminckx et al., 1991).
For the fast aggregation assay, single-cell suspensions were prepared us-
ing an E-cadherin saving procedure (Bracke et al., 1993). Cells were incu-
bated in an isotonic buffer containing 1.25 mM Ca2 under Gyrotory shak-
ing for 30 min at either 35C or 40C. Particle diameters were measured in a
particle size counter (LS 200; Beckman Coulter) at the start (t0) and after a
30-min incubation (t30), and plotted against percentage volume distribution.
Immunoprecipitation and immunoblotting
Cells were lysed in PBS with Ca2 and Mg2, containing 1% Triton X-100,
10 mM Pefablock SC (Merck), 1 mM leupeptin, 0.3 mM aprotinin, 200 M
sodium orthovanadate, and 50 mM NaF. The lysates were cleared and ad-
justed to equal protein amounts. E-cadherin and associated proteins in the
lysates were immunoprecipitated with specific antibodies and protein
G–Sepharose (Amersham Pharmacia Biotech). Immunoprecipitates and
whole-cell extracts were separated on 8% polyacrylamide gels and blotted
to PVDF membranes (Millipore). The mouse mAbs directed against
p120ctn, -catenin, and P-Tyr (PY20) were purchased from Transduction
Laboratories. Rabbit pAb against E-catenin, rat mAb DECMA-1 against
E-cadherin, and N-cadherin blocking mAb GC-4 were from Sigma-Aldrich.
Mouse mAb against N-cadherin was from Zymed Laboratories, mouse
mAb HECD-1 against E-cadherin was from Takara Biochemicals, and
mouse mAb 113H against cadherin-11 was provided by ICOS Corpora-
tion. The mAb MB2 against E-cadherin was created as previously de-
scribed by Bracke et al. (1993).
For detection of exogenous PTEN expression, we used anti-HA mAbs
(Eurogentec), anti-Xpress rabbit pAb, and anti-PTEN mAb (Santa Cruz Bio-
technology, Inc.). Anti-Akt and anti-phospho-Akt (ser 473) antibodies were
from Cell Signaling Technologies. Signals were visualized with Ig coupled
to HRP, using the ECL system (Amersham Pharmacia Biotech).
Immunofluorescence microscopy
Monolayers prepared for fluorescent staining were grown on glass cover-
slips. Cells were rinsed briefly with PBS and fixed with ice cold methanol
for 15 min at –20C. Immunostaining was performed as previously de-
scribed (van Hengel et al., 1997). The secondary antibodies used in immu-
nofluorescence microscopy were AlexaTM488-coupled Ig antibodies
(Molecular Probes). Samples were examined with a Zeiss Axiophot photo-
microscope (Carl Zeiss, Inc.).
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